TNYA
Tenaya Therapeutics, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Tenaya Therapeutics (TNYA) Stock: Buy, Sell, or Hold?
$0.35
-0.02 (-6.38%)
âŧ
5d:
+9.97%
30d:
-11.01%
90d:
-52.27%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (80%)
Quality Score
52/100
Position
SLIGHTLY LOW
30-Day Fair Range
$0.35 â $0.50
Position: SLIGHTLY LOW
Forward P/E & Valuation
-1.0x
CHEAP
vs 10.3x historical avg
Wall Street Target
$3.67
+955.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.30 / $0.41
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: TNYA is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
Get Alerted When TNYA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: TNYA is currently trading at $0.35, which is considered slightly low relative to its 30-day fair value range of $0.35 to $0.50. From a valuation perspective, the stock is trading at a discount (Forward PE: -1.0) compared to its historical average (10.3). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, TNYA is in a strong downtrend. Immediate support is located at $0.30, while resistance sits at $0.41. Short-term momentum is weak, with the stock down 6.4% recently.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $3.67 (+955.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TNYA is in a strong downtrend. Immediate support is located at $0.30, while resistance sits at $0.41. Short-term momentum is weak, with the stock down 6.4% recently.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $3.67 (+955.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.35 -
$0.50
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
Trading Range & Key Levels
30-Day Trading Range
$0.35 -
$0.50
Current vs Trading Range
SLIGHTLY LOW
Support Level
$0.30
Resistance Level
$0.41
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (43/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.4%)
- BULLISH: Trading 955.2% below Wall St target ($3.67)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 52/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.97
Wall Street Target
$3.67
(+955.2%)
PE vs Historical
-1.0 vs 10.3
CHEAP
Share TNYA Analysis
Share this live TNYA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (TNYA)
Bullish
3 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Nov 13, 2026
Daily AI digest
AI Retail Discussion Summary:
Piper Sandler lowered their price target on Tenaya Therapeutics from $40 to $6
Key Retail Themes:
Price Target
Analyst Coverage
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 4:15 AM ET
Data refreshes hourly during market hours. Next update: 5:15 AM
Data refreshes hourly during market hours. Next update: 5:15 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TNYA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 45 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
ABVX
Abivax SA American DeposâĻ |
STRONG BUY
12 analysts |
$164 | 64 BUY |
|
APLS
Apellis Pharmaceuticals âĻ |
BUY
22 analysts |
$41 | 50 HOLD |
|
STRO
Sutro Biopharma |
STRONG BUY
14 analysts |
$47 | 58 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive TNYA Research Pages
